NCT07444567: Roll-over Study for Participants Who Have Completed a Previous Clinical Study With Benralizumab (Fasenra) and Benefit From Continued Treatment
- State
- Under way
- Phase
- Phase 3
- People
- 230 planned
- Started
- 24 Jul 2026
- Primary completion
- 27 Dec 2029
- Arms
- Benralizumab arm
- Results
- None posted
- 3 Mar 2026: Trial registered
- 24 Jul 2026: Trial started